why doesn't american politics research tell me result of review

On March 20, 2020, the glyphosate ID was challenged in the U.S. It concluded that the benefits of glyphosate outweigh the potential ecological risks when glyphosate is used in accordance with labels. The ID identified interim risk mitigation measures in the form of label changes, including spray drift management language, herbicide resistance management language, a non-target organism advisory, and certain label consistency measures. The ID also identified potential ecological risks to non-target organisms, primarily non-target plants through spray drift.

EPA also found that glyphosate is unlikely to be a human carcinogen. As part of this action, EPA found that there are no risks of concern to human health when glyphosate is used in accordance with its current label. In February 2020, after receiving and considering public comments on the glyphosate proposed interim decision, EPA published the interim decision registration review decision (ID) for glyphosate. Since glyphosate’s first registration, EPA has reviewed and reassessed its safety and uses, including undergoing registration review, a program that re-evaluates each registered pesticide on a 15-year cycle.

It has been registered as a pesticide in the U.S. Glyphosate is a widely used herbicide that controls broadleaf weeds and grasses. Draft Human Health and Ecological Risk Assessments for Glyphosate.EPA Releases Draft Risk Assessments for Glyphosate.Letter to California’s Office of Environmental Health Hazard Assessment on California Proposition 65.

Why doesn't american politics research tell me result of review